These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2523648)

  • 1. Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals.
    Sauter A; Rudin M
    Am J Med; 1989 Apr; 86(4A):130-3. PubMed ID: 2523648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals.
    Sauter A; Rudin M; Wiederhold KH; Hof RP
    Am J Med; 1989 Apr; 86(4A):134-46. PubMed ID: 2523649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium antagonists for reduction of brain damage in stroke.
    Sauter A; Rudin M
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S43-7. PubMed ID: 1695302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of stroke and brain damage with calcium antagonists in animals.
    Sauter A; Rudin M
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):121S-127S. PubMed ID: 1827001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental studies with isradipine in stroke.
    Sauter A; Rudin M
    Drugs; 1990; 40 Suppl 2():44-51. PubMed ID: 2150641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of isradipine to reduce infarct size in mouse, gerbil, and rat models of cerebral ischemia.
    Bailey SJ; Wood NI; Samson NA; Rothaul AL; Roberts JC; King PD; Hamilton TC; Harrison DC; Hunter AJ
    Stroke; 1995 Nov; 26(11):2177-83. PubMed ID: 7482669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain MRI and neurological deficit measurements in focal stroke: rapid throughput validated with isradipine.
    Lenhard SC; Strittmatter R; Price WJ; Chandra S; White RF; Barone FC
    Pharmacology; 2008; 81(1):1-10. PubMed ID: 17726342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter evaluation of the safety, tolerability, and efficacy of isradipine in the treatment of essential hypertension.
    Sundstedt CD; Rüegg PC; Keller A; Waite R
    Am J Med; 1989 Apr; 86(4A):98-102. PubMed ID: 2523665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of antihypertensive treatment with isradipine on the consequences of cerebral ischaemia in the spontaneously hypertensive rat.
    Bentahila S; Atkinson J; Capdeville C
    J Hypertens; 1991 Feb; 9(2):121-9. PubMed ID: 1849526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect of isradipine in combination with captopril in hypertensive patients.
    Eggertsen R; Svensson A; Dahlöf B; Hansson L
    Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
    Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia.
    Chandra S; White RF; Everding D; Feuerstein GZ; Coatney RW; Sarkar SK; Barone FC
    Pharmacology; 1999 Jun; 58(6):292-9. PubMed ID: 10325574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
    Am J Med; 1989 Apr; 86(4A):110-4. PubMed ID: 2523644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of treatment with nilvadipine on cerebral ischemia in rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Tohoku J Exp Med; 1998 Aug; 185(4):239-46. PubMed ID: 9865470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pump performance after regression of cardiac hypertrophy following treatment of hypertension with isradipine.
    Saragoça MA; de Almeida JB; Amorim MP; Portela J; Cezaretti ML; Ramos OL
    J Hypertens Suppl; 1989 Dec; 7(6):S288-9. PubMed ID: 2534415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
    Am J Med; 1989 Apr; 86(4A):119-23. PubMed ID: 2523646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging.
    Sauter A; Rudin M
    Stroke; 1986; 17(6):1228-34. PubMed ID: 2949398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isradipine for treatment of acute hypertension after myocardial revascularization.
    Brister NW; Barnette RE; Schartel SA; McClurken JB; Alpern J
    Crit Care Med; 1991 Mar; 19(3):334-8. PubMed ID: 1825628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.